Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimaging and CBD for Opioid Use Disorder

NCT04567784 is registered in ClinicalTrials.gov with Yasmin Hurd as lead sponsor.

NCT NCT04567784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04567784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimaging and CBD for Opioid Use Disorder
Lead sponsor
Yasmin Hurd
Phase
Phase 2
Overall status
Completed
Start date
November 12, 2020
Completion date
June 18, 2025
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heroin abuse, opioid use disorder, opioid-related disorders, substance-related disorders